Super-Resolution Fluorescence Imaging Reveals the Role of CD24 Clusters in NSCLC Proliferation

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• CD24, a cell surface protein, is dysregulated in non-small-cell lung cancer (NSCLC), impacting tumor growth and immune evasion.
• The nanoscale organization and specific functional role of CD24 in NSCLC proliferation are not fully understood.

Purpose of the Study:

• To investigate the nanoscale spatial organization of CD24 in NSCLC.
• To determine the functional relevance of CD24 clustering to NSCLC proliferation.
• To elucidate the molecular mechanisms underlying CD24-driven NSCLC proliferation.

Main Methods:

• Direct stochastic optical reconstruction microscopy (dSTORM) was used to visualize CD24 clusters in NSCLC cell lines, primary cells, and tissues.
• A specific Asn36 single-point mutant was employed to differentiate the effects of CD24 clustering from expression levels.
• Western blotting and PI3K inhibitor treatment were used to assess pathway activation.

Main Results:

• Increased CD24 clustering was observed and correlated with enhanced NSCLC proliferation.
• Disruption of CD24 clustering, via the Asn36 mutant, suppressed NSCLC cell proliferation.
• CD24 clustering inhibition reduced the phosphorylation of PI3K, AKT, and mTOR, indicating involvement of the PI3K/AKT/mTOR pathway.

Conclusions:

• CD24 nanoscale clustering, not merely its expression, is a key driver of NSCLC proliferation.
• The PI3K/AKT/mTOR signaling axis is implicated in CD24 clustering-mediated tumorigenesis.
• CD24 clustering represents a potential prognostic biomarker and therapeutic target for NSCLC.